id	metarevistapublica_asoneumocito_revistacolombianadeneumologia_28_article_416
record_format	ojs
spelling	INTRODUCTION: Viral infections such as the one emerging from COVID 19 produce hypercoagulable and pro-inflammatory states that can trigger pulmonary thromboembolism, being a diagnostic and therapeutic challenge for health personnel. Being a new disease, all of its symptoms are not yet known. We present the clinical case of a patient with acute dyspnea and hemoptysis secondary to segmental pulmonary embolism, in the context of confirmed COVID-19 infection. CASE PRESENTATION: A 37-year-old male patient with a history of arterial hypertension, without prothrombotic risk factors, with acute symptoms of chest pain, dyspnea and frank hemoptysis. Paraclinical patients with d-dimer and elevated ferritin, positive SARSCOV2 RTPCR, chest CT angiography showing segmental pulmonary thromboembolism and ground glass pattern in the anterior basal segment of the lower lobe. He complied with antibiotic and anticoagulant management with full dose enoxaparin and subsequently with direct oral anticoagulant, rivaroxaban on an outpatient basis. CONCLUSION: Infection by the new coronavirus can trigger thrombotic events such as pulmonary embolism, which becomes a diagnostic and therapeutic challenge for clinicians, with a presentation that ranges from general to more specific symptoms, among which hemoptysis stands out, which is why which, the present one aims to show the importance of a sequential evaluation when making the clinical diagnosis. In the same way, to expose the need not to neglect the atypical manifestations related to hypercoagulable states, since they cannot suggest pathologies that put the patient's life at risk. Martinez Avila, Maria Cristina Almanza Hurtado, Amilkar Jose Mondol, Zulay Trespalacios Sierra, Alvano Blanquicett, Alejandro de Jesus Pineda Paternina, Mario Andrés Mesa Gamarra, Kelly hemoptisis tromboembolismo pulmonar hipercoagulabilidad COVID 19 SARS COV2 presentación atípica. Hemoptysis pulmonary embolism hypercoagulability COVID 19 SARS CoV-2 atypical presentations 33 1 Artículo de revista Journal article 2021-10-13T16:17:57Z 2021-10-13T16:17:57Z 2021-10-13 application/pdf Asociación Colombiana de Neumología y Cirugía de Tórax Revista Colombiana de Neumología 0121-5426 2538-9513 https://revistas.asoneumocito.org/index.php/rcneumologia/article/view/416 10.30789/rcneumologia.v33.n1.2021.416 https://doi.org/10.30789/rcneumologia.v33.n1.2021.416 spa https://creativecommons.org/licenses/by-nc-sa/4.0/ Revista Colombiana de Neumología - 2021 31 36 https://revistas.asoneumocito.org/index.php/rcneumologia/article/download/416/478 info:eu-repo/semantics/article http://purl.org/coar/resource_type/c_6501 http://purl.org/coar/resource_type/c_dcae04bc http://purl.org/redcol/resource_type/ARTREV info:eu-repo/semantics/publishedVersion http://purl.org/coar/version/c_970fb48d4fbd8a85 info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2 Text Publication
institution	ASOCIACION COLOMBIANA DE NEUMOLOGIA Y CIRUGIA DE TORAX
thumbnail	https://nuevo.metarevistas.org/ASOCIACIONCOLOMBIANADENEUMOLOGIAYCIRUGIADETORAX/logo.png
country_str	Colombia
collection	Revista Colombiana de Neumología
description_eng	INTRODUCTION: Viral infections such as the one emerging from COVID 19 produce hypercoagulable and pro-inflammatory states that can trigger pulmonary thromboembolism, being a diagnostic and therapeutic challenge for health personnel. Being a new disease, all of its symptoms are not yet known. We present the clinical case of a patient with acute dyspnea and hemoptysis secondary to segmental pulmonary embolism, in the context of confirmed COVID-19 infection. CASE PRESENTATION: A 37-year-old male patient with a history of arterial hypertension, without prothrombotic risk factors, with acute symptoms of chest pain, dyspnea and frank hemoptysis. Paraclinical patients with d-dimer and elevated ferritin, positive SARSCOV2 RTPCR, chest CT angiography showing segmental pulmonary thromboembolism and ground glass pattern in the anterior basal segment of the lower lobe. He complied with antibiotic and anticoagulant management with full dose enoxaparin and subsequently with direct oral anticoagulant, rivaroxaban on an outpatient basis. CONCLUSION: Infection by the new coronavirus can trigger thrombotic events such as pulmonary embolism, which becomes a diagnostic and therapeutic challenge for clinicians, with a presentation that ranges from general to more specific symptoms, among which hemoptysis stands out, which is why which, the present one aims to show the importance of a sequential evaluation when making the clinical diagnosis. In the same way, to expose the need not to neglect the atypical manifestations related to hypercoagulable states, since they cannot suggest pathologies that put the patient's life at risk.
author	Martinez Avila, Maria Cristina Almanza Hurtado, Amilkar Jose Mondol, Zulay Trespalacios Sierra, Alvano Blanquicett, Alejandro de Jesus Pineda Paternina, Mario Andrés Mesa Gamarra, Kelly
spellingShingle	Martinez Avila, Maria Cristina Almanza Hurtado, Amilkar Jose Mondol, Zulay Trespalacios Sierra, Alvano Blanquicett, Alejandro de Jesus Pineda Paternina, Mario Andrés Mesa Gamarra, Kelly hemoptisis tromboembolismo pulmonar hipercoagulabilidad COVID 19 SARS COV2 presentación atípica. Hemoptysis pulmonary embolism hypercoagulability COVID 19 SARS CoV-2 atypical presentations
author_facet	Martinez Avila, Maria Cristina Almanza Hurtado, Amilkar Jose Mondol, Zulay Trespalacios Sierra, Alvano Blanquicett, Alejandro de Jesus Pineda Paternina, Mario Andrés Mesa Gamarra, Kelly
topicspa_str_mv	hemoptisis tromboembolismo pulmonar hipercoagulabilidad COVID 19 SARS COV2 presentación atípica.
topic	hemoptisis tromboembolismo pulmonar hipercoagulabilidad COVID 19 SARS COV2 presentación atípica. Hemoptysis pulmonary embolism hypercoagulability COVID 19 SARS CoV-2 atypical presentations
topic_facet	hemoptisis tromboembolismo pulmonar hipercoagulabilidad COVID 19 SARS COV2 presentación atípica. Hemoptysis pulmonary embolism hypercoagulability COVID 19 SARS CoV-2 atypical presentations
citationvolume	33
citationissue	1
publisher	Asociación Colombiana de Neumología y Cirugía de Tórax
ispartofjournal	Revista Colombiana de Neumología
source	https://revistas.asoneumocito.org/index.php/rcneumologia/article/view/416
language	spa
format	Article
rights	https://creativecommons.org/licenses/by-nc-sa/4.0/ Revista Colombiana de Neumología - 2021 info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2
type_driver	info:eu-repo/semantics/article
type_coar	http://purl.org/coar/resource_type/c_6501
type_version	info:eu-repo/semantics/publishedVersion
type_coarversion	http://purl.org/coar/version/c_970fb48d4fbd8a85
type_content	Text
publishDate	2021-10-13
date_accessioned	2021-10-13T16:17:57Z
date_available	2021-10-13T16:17:57Z
url	https://revistas.asoneumocito.org/index.php/rcneumologia/article/view/416
url_doi	https://doi.org/10.30789/rcneumologia.v33.n1.2021.416
issn	0121-5426
eissn	2538-9513
doi	10.30789/rcneumologia.v33.n1.2021.416
citationstartpage	31
citationendpage	36
url2_str_mv	https://revistas.asoneumocito.org/index.php/rcneumologia/article/download/416/478
_version_	1811200715695063040

.

Código QR

Estadísticas y Métricas Alternativas

Títulos similares